Patents by Inventor Adam Linder

Adam Linder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190079104
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Application
    Filed: September 21, 2018
    Publication date: March 14, 2019
    Inventors: Lars BJÖRCK, Bertil CHRISTENSSON, Heiko HERWALD, Adam LINDER, Per AKESSON
  • Patent number: 10126312
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: November 13, 2018
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Patent number: 9784741
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: October 10, 2017
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Patent number: 9759720
    Abstract: It has been demonstrated that the level of HBP increases in individuals that have bacterial meningitis. Accordingly, the level of HBP in an individual can be used to determine whether or not an individual has bacterial meningitis.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: September 12, 2017
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Publication number: 20160252529
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 1, 2016
    Inventors: Lars BJÖRCK, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Publication number: 20140187503
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Application
    Filed: December 2, 2013
    Publication date: July 3, 2014
    Applicant: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Publication number: 20140080754
    Abstract: It has been demonstrated that the level of HBP increases in individuals that have bacterial meningitis. Accordingly, the level of HBP in an individual can be used to determine whether or not an individual has bacterial meningitis.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 20, 2014
    Applicant: HANSA MEDICAL AB
    Inventors: Lars Björck, Bertil Christensson, Adam Linder, Heiko Herwald, Per Åkesson
  • Publication number: 20140080925
    Abstract: It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
    Type: Application
    Filed: February 7, 2012
    Publication date: March 20, 2014
    Applicant: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Publication number: 20130252347
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 26, 2013
    Applicant: Hansa Medical AB
    Inventors: Lars Bjorck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Akesson
  • Patent number: 8518648
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Grant
    Filed: June 12, 2008
    Date of Patent: August 27, 2013
    Assignee: Hansa Medical AB
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson
  • Publication number: 20100305185
    Abstract: It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
    Type: Application
    Filed: June 12, 2008
    Publication date: December 2, 2010
    Inventors: Lars Björck, Bertil Christensson, Heiko Herwald, Adam Linder, Per Åkesson